| mRNA |
MLN4924 |
CTRPv2 |
pan-cancer |
AAC |
0.076 |
0.04 |
| mRNA |
niclosamide |
CTRPv2 |
pan-cancer |
AAC |
-0.08 |
0.05 |
| mRNA |
CAL-101 |
CTRPv2 |
pan-cancer |
AAC |
0.08 |
0.05 |
| mRNA |
ML320 |
CTRPv2 |
pan-cancer |
AAC |
0.079 |
0.05 |
| mRNA |
carboplatin:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.081 |
0.05 |
| mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.077 |
0.05 |
| mRNA |
Bexarotene |
GDSC1000 |
pan-cancer |
AAC |
0.069 |
0.05 |
| mRNA |
PHA-665752 |
GDSC1000 |
pan-cancer |
AAC |
0.1 |
0.05 |
| mRNA |
YK 4-279 |
CTRPv2 |
pan-cancer |
AAC |
0.069 |
0.05 |
| mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
-0.096 |
0.05 |